Feb 10, 2025 · The new facility, known as the Arkelia project is a milestone of our long-term strategy to push the boundaries of science and deliver life-changing solutions for people living with severe diseases worldwide.

Designed to enhance the Campus's role as a global hub for innovative research, development, manufacturing and supply, the facility, known as the Arkelia project, aims to strengthen UCB’s position as a leader in delivering breakthrough solutions for patients worldwide. This project represents an investment of over 100 million euros.

Feb 10, 2025 · Belgian biopharmaceutical company UCB announced on Monday the construction of a new research and development centre on its campus in Braine-l'Alleud (Walloon Brabant). The project, named Arkelia, will focus on research in …

Feb 10, 2025 · Driving innovation forward: UCB unveils new R&D facility Read More. Subscribe to Arkelia Choose a Country. Global Site – English; Australia – English; België – Engels; Belgique – Anglais; Brasil – Português;

Arkelia represents a major milestone in UCB’s mission to push scientific boundaries and create life-changing solutions for people living with severe diseases.

We’re building the future of innovation Thrilled to announce the development of Arkelia, a state-of-the-art R&D facility at our Braine-l’Alleud… | 17 comments on LinkedIn

L'entreprise biopharmaceutique belge UCB a annoncé lundi la construction d'un nouveau centre de recherche et développement sur son campus de Braine-l'Alleud (Brabant wallon). Il s'agira d'un...

AECOM is thrilled to have designed Arkelia from its inception and to be part of delivering a cutting-edge building solution that will empower UCB’s researchers to excel in developing...

UCB (Union Chimique Belge) is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 [2] which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. [2]

De faciliteit, bekend als het Arkelia-project, is ontworpen om de rol van de campus als wereldwijde hub voor innovatief onderzoek, ontwikkeling, productie en levering te versterken en heeft als doel de positie van UCB als leider van in het leveren van baanbrekende oplossingen voor patiënten wereldwijd te versterken.